Company Overview of S1 Biopharma Inc
S1 Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for sexual dysfunction. The company has a portfolio of four clinical and pre-clinical stage drug candidates. Its principal product candidate is Lorexys, a proprietary fixed-dose combination therapy for the treatment of female hypoactive sexual desire disorder (HSDD). The company also develops Orexa for the treatment of male HSDD. In addition, it develops two pre-clinical candidates, including S1B-307, a peptide for the treatment of female sexual arousal disorder and female orgasmic disorder; and S1B-3006, a proprietary second-generation agent combining active compound...
7 World Trade Center
250 Greenwich Street
New York City, NY 10007
Founded in 2010
Key Executives for S1 Biopharma Inc
Chairman, Chief Executive Officer and President
Chief Medical Officer and Member of Advisory Board
Compensation as of Fiscal Year 2017.
S1 Biopharma Inc Key Developments
S1 Biopharma, Inc. and CKD Pharmaceuticals Enter into Commercialization Agreement for Lorexys
Dec 8 15
S1 Biopharma Inc. and CKD Pharmaceuticals announced that they have entered into a commercialization agreement for Lorexys™, S1 Biopharma's investigational therapy currently positioned to advance to a Phase 2b clinical trial for treatment of HSDD in women. Under the terms of the agreement, CKD acquires rights to commercialize Lorexys throughout South Korea. The terms include an upfront payment to S1 Biopharma and additional payments based on milestones as well as royalties on future product sales. CKD also has right of first refusal for commercialization agreements related to additional potential indications for Lorexys.
S1 Biopharma Inc Presents at Sofinnova Japan Biopharma Partnering Conference 2015, Oct-27-2015 05:30 PM
Oct 1 15
S1 Biopharma Inc Presents at Sofinnova Japan Biopharma Partnering Conference 2015, Oct-27-2015 05:30 PM. Venue: Conrad Hotel, 1-9-1, Higashi-Shinbashi, Minato-Ku, Tokyo, 105 7337, Japan.
S1 Biopharma Inc Presents at BIO-Europe 2015, Nov-03-2015 11:15 AM
Sep 21 15
S1 Biopharma Inc Presents at BIO-Europe 2015, Nov-03-2015 11:15 AM. Venue: Munich, Germany.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries